Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease

Yongfeng Song1, Ling Gao1

  • 1Department of Endocrinology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Department of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong 250021, China; Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong 250021, China; Institute of Endocrinology and metabolism, Shandong Academy of Clinical Medicine, Jinan, Shandong 250021, China.

Ebiomedicine
|July 23, 2020
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos